Overview

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of different combination chemotherapy regimens in treating infants who have newly diagnosed neuroblastoma.
Phase:
Phase 2
Details
Lead Sponsor:
European Infant Neuroblastoma Study Group - 1999
Treatments:
Carboplatin
Cyclophosphamide
Doxorubicin
Etoposide
Liposomal doxorubicin
Vincristine